FANTIVIR

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

famciclovir, Quantity: 125 mg

Disponibbli minn:

Southern Cross Pharma Pty Ltd

INN (Isem Internazzjonali):

Famciclovir

Għamla farmaċewtika:

Tablet, film coated

Kompożizzjoni:

Excipient Ingredients: colloidal anhydrous silica; microcrystalline cellulose; sodium stearylfumarate; copovidone; crospovidone; titanium dioxide; macrogol 8000; hypromellose; polydextrose; triethyl citrate

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

40 tablets

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

Famciclovir is indicated for: ? Treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. Greatest benefit occurs if the drug is started within 48 hours. Efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. Herpes zoster infection is generally a milder condition in younger patients. ? Treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older. ? Suppression of recurrent genital herpes. ? Treatment of recurrent herpes labialis (cold sores) in immunocompetent adult patients.,Famciclovir is also indicated in immunocompromised patients for: ? Treatment of uncomplicated herpes zoster. ? Treatment of recurrent herpes simplex. ? Suppression of recurrent herpes simplex.

Sommarju tal-prodott:

Visual Identification: White round film coated tablets with FM on one side and 125 on the other side; Container Type: Bottle; Container Material: HDPE; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2012-08-14